InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the full record of transactions filed by Lettmann Jason, Director. Director active across 1 companies, notably ALX Oncology Holdings INC. Aggregated, 4 disclosures have been recorded. Total volume traded: €2.6m. The latest transaction was disclosed on 13 December 2021 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€267,05611,945 shares@ €22.35710.098% mcap20.2% of flow
Common Stock
SEC:0000899243-21-048463·
€267,05611,945 shares@ €22.35710.098% mcap10.1% of flow
Common Stock
SEC:0000899243-21-048463:0·
€1m35,836 shares@ €29.46840.39% mcap79.8% of flow
Common Stock
SEC:0001209191-21-069154·
€1m35,836 shares@ €29.46840.39% mcap39.9% of flow
Common Stock
SEC:0001209191-21-069154:0·
4 of 4 declarations
About Lettmann Jason
Jason Lettmann is a Board Member at ALX Oncology Holdings Inc. He plays a key role in the company's governance, contributing to strategy and decision-making. His experience is valuable for the development of ALX Oncology.
